share_log

Maxeon Solar Technologies | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Maxeon Solar Technologies | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Maxeon Solar Technologies | 6-K:外國發行人報告
美股SEC公告 ·  2024/09/12 05:24

Moomoo AI 已提取核心訊息

Maxeon Solar Technologies held its Annual General Meeting on August 29, 2024, where shareholders approved all seven proposals on the agenda. The approved items included the adoption of the 2023 financial statements, the election of Li David H as Director, and the reappointment of Ernst & Young LLP as auditors.Key corporate actions approved by shareholders encompassed the authorization for Directors to issue shares under Section 161 of the Companies Act, the renewal of both FPTC Share Purchase Mandate and MLI Share Buyback Mandate, and the Proposed Share Consolidation. The meeting achieved quorum through proxy representation of outstanding ordinary shares.
Maxeon Solar Technologies held its Annual General Meeting on August 29, 2024, where shareholders approved all seven proposals on the agenda. The approved items included the adoption of the 2023 financial statements, the election of Li David H as Director, and the reappointment of Ernst & Young LLP as auditors.Key corporate actions approved by shareholders encompassed the authorization for Directors to issue shares under Section 161 of the Companies Act, the renewal of both FPTC Share Purchase Mandate and MLI Share Buyback Mandate, and the Proposed Share Consolidation. The meeting achieved quorum through proxy representation of outstanding ordinary shares.
Maxeon Solar Technologies於2024年8月29日舉行了年度股東大會,股東們批准了議程上的七項提案。批准的內容包括通過2023年基本報表、選舉李大衛H爲董事,以及重新任命安永會計師事務所作爲核數師。股東批准的主要公司行動包括授權董事根據《公司法》第161條發行股份、續期FPTC股份購買授權和MLI股票回購授權,以及提議的股份合併。會議通過代理代表達成了法定人數,涵蓋了所有普通股。
Maxeon Solar Technologies於2024年8月29日舉行了年度股東大會,股東們批准了議程上的七項提案。批准的內容包括通過2023年基本報表、選舉李大衛H爲董事,以及重新任命安永會計師事務所作爲核數師。股東批准的主要公司行動包括授權董事根據《公司法》第161條發行股份、續期FPTC股份購買授權和MLI股票回購授權,以及提議的股份合併。會議通過代理代表達成了法定人數,涵蓋了所有普通股。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息